Boston Trust Walden’s SAPIENT CORP SAPE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-2,530,704
Closed -$35.4M 343
2014
Q3
$35.4M Sell
2,530,704
-94,812
-4% -$1.41M 0.55% 64
2014
Q2
$42.7M Buy
2,625,516
+41,549
+2% +$683K 0.62% 56
2014
Q1
$44.1M Sell
2,583,967
-632,321
-20% -$10.6M 0.65% 54
2013
Q4
$55.8M Sell
3,216,288
-213,392
-6% -$3.39M 0.81% 32
2013
Q3
$53.5M Sell
3,429,680
-58,152
-2% -$859K 0.82% 26
2013
Q2
$45.6M Buy
+3,487,832
New +$42M 0.74% 40

Other funds holding SAPE

Boston Trust Walden's SAPE Position: Q4 2014 in Review

Boston Trust Walden sold out of SAPIENT CORP (SAPE) in Q4 2014, closing a stake of 2,530,704 shares — an estimated $35.4M sold.

Boston Trust Walden first reported a position in SAPE in Q2 2013 and held it in 6 quarters. The position peaked at $55.8M in Q4 2013. 166 funds tracked by Wall St. Rank hold SAPE as of Q4 2014.

  • Boston Trust Walden reported no remaining SAPIENT CORP position as of Q4 2014 after selling out during the quarter.
  • Boston Trust Walden sold 2,530,704 SAPIENT CORP shares in Q4 2014, an estimated $35.4M.
  • Boston Trust Walden first reported a position in SAPIENT CORP in Q2 2013 and held it in 6 quarters.
  • Boston Trust Walden's SAPIENT CORP position peaked at $55.8M in Q4 2013.
  • 166 funds tracked by Wall St. Rank held SAPIENT CORP as of Q4 2014.

Based on Boston Trust Walden's 13F filing for Q4 2014, filed 28 Jan 2015.